SCHEMBL3836641

SCHEMBL3836641

CCC1CCCCN1ON

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.38
TP53 P04637 1/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
PSEN1 P49768 1/20 0.34
PSEN2 P49810 1/20 0.34
APH1B Q8WW43 1/20 0.34
NCSTN Q92542 1/20 0.34
APH1A Q96BI3 1/20 0.34
PSENEN Q9NZ42 1/20 0.34
ALDH1A1 P00352 4/20 0.34
CRHBP P24387 1/20 0.34
CRHR2 Q13324 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CYP1A2 P05177 1/20 0.33
NPC1 O15118 1/20 0.33
HPGD P15428 1/20 0.33
RAB9A P51151 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4461975 0.85 MAPK1 (0.40) KMT2ATP53TSHRMAPK1PSEN1
SCHEMBL28284568 0.79 KMT2A (0.38) KMT2ATP53TSHRMAPK1PSEN1
SCHEMBL27772509 0.78
SCHEMBL4970559 0.75 TP53 (0.36) KMT2ATP53TSHRMAPK1PSEN1
SCHEMBL7704576 0.73 MAPT (0.38) KMT2ATP53TSHRALDH1A1SMN1; SMN2
SCHEMBL28260453 0.72 KMT2A (0.32) KMT2ATP53TSHRMAPK1ALDH1A1
SCHEMBL8555817 0.71
SCHEMBL17121688 0.71
SCHEMBL17121689 0.71
Bromide SCHEMBL28261743 0.71 KMT2A (0.31) KMT2ANPC1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090023666-A1 Modulators of Hypoxia Inducible Factor-1 and Related Uses BTG plc (GB) 2009-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090023666-A1 Modulators of Hypoxia Inducible Factor-1 and Related Uses HIF1A, HIF1AN, HYOU1 KMT2A 2206/4885TP53 1892/4885TSHR 2278/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.